יחס חוב כולל להון עצמי eEFFECTOR Therapeutics Inc. (EFTR)

This market valuation chart for eFFECTOR Therapeutics (EFTR) demonstrates the 0.00 metric, while the business optimizes the supply of chemical components for tests through a network of laboratories. However, patent protection has been lost due to the collapse of medical tests and the firm's impending closure. The organization currently operates as a compact scientific staff, outsourcing drug production and drug verification to third-party contractors.

This metric measures the proportion of borrowed funds relative to equity, determining the degree of financial autonomy and default risks associated with servicing obligations. An analysis of the total debt-to-equity ratio allows for an assessment of the stability of eFFECTOR Therapeutics (EFTR), whose sovereign medicine business is shielded from global crises by stable demand for innovative developments.